Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04108182
NCT04108182
Recruiting
Not Applicable

A Registry Study of Biomarkers in Progression of Acute Heart Failure

Beijing Institute of Heart, Lung and Blood Vessel Diseases1 site in 1 country850 target enrollmentDecember 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCardiovascular Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Diseases
Sponsor
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Enrollment
850
Locations
1
Primary Endpoint
Number of death ( all cause) or readmission for heart failure
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The registry study aims to discover the prognostic value of bio-markers in acute heart failure

Registry
clinicaltrials.gov
Start Date
December 2015
End Date
October 2025
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Patients aged greater than or equal to 18 years with acute exacerbation of chronic heart failure or new heart failure
  • •With typical symptoms of acute heart failure as follows: Dyspnea, ankle swelling and fatigue (Limited activity endurance), increased jugular pressure, rales and peripheral edema ;
  • •Plasma concentrations of BNP: BNP\>100pg/ML
  • •Echocardiography: Related structural heart disease (left ventricular hypertrophy and/or left atrial enlargement) and/or diastolic dysfunction

Exclusion Criteria

  • •Previous history of cancer or renal replacement therapy
  • •2.Surgery was performed within a month
  • •3.Accompanied by cardiogenic shock, sepsis, pneumonia
  • •4.Eligible patients without informed consent form

Outcomes

Primary Outcomes

Number of death ( all cause) or readmission for heart failure

Time Frame: a median follow-up of 8.8 months

Number of Death or heart failure related hospitalization within a median follow-up of 8.8 months of discharge

Secondary Outcomes

  • Number of death ( all cause) or readmission for heart failure and cardiovascular mortality(a median follow-up of 8.8 months)

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
A Registry Study of Biomarkers in Heart FailureCardiovascular Diseases
NCT03784833Beijing Institute of Heart, Lung and Blood Vessel Diseases5,000
Recruiting
Not Applicable
A Registry Study of Biomarkers in Ischemic Heart Disease ( BIOMS-IHD )Cardiovascular Diseases
NCT05965882Beijing Institute of Heart, Lung and Blood Vessel Diseases5,000
Recruiting
Not Applicable
Prognostic and Diagnostic Value of Biomarkers and Cardiac Functional Parameters in Patients With Chronic Heart FailureChronic Heart Failure
NCT02776384Shanghai Jiao Tong University School of Medicine1,000
Recruiting
Not Applicable
A Registry Study of Biomarkers in Mitral Valve Disease (BIOMS-MVD)Cardiovascular Diseases
NCT05141292Beijing Institute of Heart, Lung and Blood Vessel Diseases5,000
Completed
Not Applicable
Mbarara Acute Heart Failure RegistryHeartfailure
NCT02721030Mbarara University of Science and Technology217